Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.
Rainbows, jelly beans, lip glosses…there are plenty of things we want to see in a spectrum of colors. Our stool, however, isn ...